Clinical parameters affecting dapagliflozin response in patients with type 2 diabetes

Diabetes Metab. 2017 Apr;43(2):191-194. doi: 10.1016/j.diabet.2016.11.005. Epub 2017 Jan 11.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Benzhydryl Compounds / therapeutic use*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / epidemiology
  • Female
  • Glucosides / therapeutic use*
  • Glycated Hemoglobin / analysis
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Male
  • Middle Aged
  • Retrospective Studies

Substances

  • Benzhydryl Compounds
  • Glucosides
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • hemoglobin A1c protein, human
  • dapagliflozin